Levent KARACA, ER Yeşim ÖZTAŞ, Cağdaş ÖZDÖL

Plasma LDL subtype distribution in patients with or without coronary stenosis

Plasma low density lipoprotein (LDL) had 3 subtypes according to its separation by polyacrylamide gradient gel electrophoresis. Of these, the small, dense (Sd) LDL particles have been accepted as an emerging cardiovascular risk factor. This study was conducted to assess the LDL subtypes in a group of patients undergoing coronary angiography. Materials and methods: The study involved 56 patients—36 of whom had at least 1 vessel stenosed (stenosis group)—and 20 patients who had no stenosis (non-stenosis group). LDL subtypes were determined according to their migration pattern after non-denaturing gradient gel electrophoresis. Total cholesterol, LDL and high density lipoprotein (HDL), and triglyceride levels were also evaluated. Results: Sd LDL positivity was slightly increased in the stenosis group, but the difference was not significant. Mean HDL levels were lower in the stenosis group; other lipid parameters were similar between the groups. Patients with Sd LDL positivity had significantly higher levels of triglyceride (P < 0.005). Conclusion: In the current study Sd LDL positivity was relatively higher in coronary stenosis patients; however, it is not statistically significant.

Anahtar Kelimeler:

Key words: Lipoprotein, Sd LDL, atherosclerosis, coronary stenosis

Plasma LDL subtype distribution in patients with or without coronary stenosis

Keywords:

Key words: Lipoprotein, Sd LDL, atherosclerosis, coronary stenosis,

PDF

___

Onat A. On the Pathophysiology of Excess Coronary Morbidity and Mortality Among Turks: Implications for Detection and Prevention. Turk Kardiyol Dern Ars 2001; 29: 602-609.
Onat A, Sansoy V, Erer B, Basar O, Ceyhan K. Coronary Morbidity and Mortality Estimates in the TEKHARF Survey of 2001. Turk Kardiyol Dern Ars 2001; 29: 633-636.
Szklo M, Chambless LE, Folsom AR, Gotto AJ, Nieto FJ, Patsch W et al. Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. Prev Med 2000; 30: 252-9.
Ginsberg HN. Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer. Ann Intern Med 1997; 126: 912-4.
Khawaja FJ, Kullo IJ. Novel markers of peripheral arterial disease. Vasc Med 2009; 14: 381-92. 6. Shen MM, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981; 22: 236-44. 7. Bjornheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996; 123: 43-56.
Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 1993; 34: 295-308. 9. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506.
Th ird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fi nal report. Circulation 2002; 106: 3143-421.
Krauss R. Low density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol 1991; 2: 248-252.
Rifai N, Bachorik PS, Albers JJ. Lipids, Lipoproteins, and Apolipoproteins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: Saunders Company; 1999. p. 839-841.
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
Krauss RM, Burke DJ. Identifi cation of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104.
Bloom DJ, Byrnes P, Jones S, Marais D. Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia. J Lipid Res 2003; 44: 212-217.
Kwiterovich, PO. Clinical relevance of the biochemical, metabolic, and genetic factors that infl uence low-density lipoprotein heterogeneity. Am J Cardiol 2002; 90: 30i-47i.
Griffi n BA, Freeman DJ, Tait GW, Th omson J, Caslake MJ, Packard CJ et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241-53.
Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low- density lipoprotein subfractions in patients with metabolic syndrome defi ned according to the National Cholesterol Education Program criteria. Metabolism 2006; 55: 885-91.
Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-8.
Mykkanen L, Kuusisto J, Haff ner SM, Laakso M, Austin MA. LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Th romb Vasc Biol 1999; 19: 2742-8.
Yeo Y, Byun SW, Lee JY, Min WK, Park JS, Kim SB. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients. Am J Nephrol 2009; 30: 310-4.
Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ et al. Small dense LDL particles as a predictor of risk of ischemic heart disease in men. Circulation 1997; 95: 69-75.
Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low- density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001; 286: 1468-74.
Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32: 1741-53.
Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DCJ et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007; 192: 211-217.
Rizzo M, Berneis K, Koulouris S, Pastromas S, Rini GB, Sakellariou D et al. Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes? Int J Clin Pract 2010; 64: 1631-42.
Mora S. Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. Circulation 2009; 119: 2396-404.